×
×
×
×
×

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
  
data?.title

Expanding Opportunities Across International Markets

June 2, 2026

Portfolio Managers Andrew Mathewson and Michael Testorf highlight AI leadership, attractive valuations and the benefits of a quality growth approach when investing in developed and emerging markets. They also discuss key sectors and regions of focus in their respective strategies.

Related Perspectives

Tailwinds Forming for Health Care
Podcast: Improved biopharma funding is proving beneficial to CROs and life science tools companies while patent expirations are separating pharmaceuticals.
Balancing AI Momentum with Regional Exposures
Emerging Markets 2Q26: We are managing concentration risk through allocations to China and India while maintaining dedicated exposure to secular AI growth trends.
Participating Broadly in AI Infrastructure Buildout
International Growth ADR 2Q26: International equities rebounded sharply, with AI-linked technology companies driving outperformance for the Strategy.
Midyear Outlook: What Wall of Worry?
The AOR team offers a bullish view for the second half of 2026, with a strengthening economy and robust earnings offsetting an energy shock and a hawkish Fed.
Emerging Markets Monthly Update
Emerging Markets May 2026: The Strategy outperformed in a narrow market environment due to stock selection among technology stocks, primarily in South Korea.
More
  • Past performance is no guarantee of future results. Copyright © 2026 ClearBridge Investments. All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information.

  • Performance source: Internal. Benchmark source: Morgan Stanley Capital International. Neither ClearBridge Investments, LLC nor its information providers are responsible for any damages or losses arising from any use of this information. Performance is preliminary and subject to change. Neither MSCI nor any other party involved in or related to compiling, computing or creating the MSCI data makes any express or implied warranties or representations with respect to such data (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any of such data. Without limiting any of the foregoing, in no event shall MSCI, any of its affiliates or any third party involved in or related to compiling, computing or creating the data have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages. No further distribution or dissemination of the MSCI data is permitted without MSCI’s express written consent. Further distribution is prohibited. 
more